Cover Image
市場調查報告書

Asubio製藥的產品平台分析

Asubio Pharma Co., Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321951
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
Asubio製藥的產品平台分析 Asubio Pharma Co., Ltd. - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 24 Pages
簡介

Asubio製藥(Asubio Pharma Co., Ltd.)從事的是第一三共的子公司業務,提供針對製藥企業研究開發及臨床研究的服務。對像領域有血管系統疾病,惡性腫瘤,感染疾病,免疫系過敏疾病,神經系統等。

本報告提供Asubio製藥的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,同時也提供最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Asubio製藥的基本資料

  • Asubio製藥概要
  • 主要資訊
  • 企業資料

Asubio製藥:R&D概要

  • 主要的治療範圍

Asubio製藥:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Asubio製藥:開發中產品概況

  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Asubio製藥:藥物簡介

  • SUN-13837
  • SUN-11602
  • Small Molecules for Undisclosed Indication

Asubio製藥:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Asubio製藥:最新的開發平台資訊

Asubio製藥:總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06932CDB

Summary

Global Markets Direct's, 'Asubio Pharma Co., Ltd. - Product Pipeline Review - 2015', provides an overview of the Asubio Pharma Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Asubio Pharma Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Asubio Pharma Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Asubio Pharma Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Asubio Pharma Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Asubio Pharma Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Asubio Pharma Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Asubio Pharma Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Asubio Pharma Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Asubio Pharma Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Asubio Pharma Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Asubio Pharma Co., Ltd. Snapshot
    • Asubio Pharma Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Asubio Pharma Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Asubio Pharma Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Asubio Pharma Co., Ltd. - Pipeline Products Glance
    • Asubio Pharma Co., Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Asubio Pharma Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Asubio Pharma Co., Ltd. - Drug Profiles
    • SUN-13837
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ASB-14780
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SUN-11602
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Asubio Pharma Co., Ltd. - Pipeline Analysis
    • Asubio Pharma Co., Ltd. - Pipeline Products by Target
    • Asubio Pharma Co., Ltd. - Pipeline Products by Route of Administration
    • Asubio Pharma Co., Ltd. - Pipeline Products by Molecule Type
    • Asubio Pharma Co., Ltd. - Pipeline Products by Mechanism of Action
  • Asubio Pharma Co., Ltd. - Recent Pipeline Updates
  • Asubio Pharma Co., Ltd. - Dormant Projects
  • Asubio Pharma Co., Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Asubio Pharma Co., Ltd., Key Information
  • Asubio Pharma Co., Ltd., Key Facts
  • Asubio Pharma Co., Ltd. - Pipeline by Indication, 2015
  • Asubio Pharma Co., Ltd. - Pipeline by Stage of Development, 2015
  • Asubio Pharma Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Asubio Pharma Co., Ltd. - Phase II, 2015
  • Asubio Pharma Co., Ltd. - Preclinical, 2015
  • Asubio Pharma Co., Ltd. - Discovery, 2015
  • Asubio Pharma Co., Ltd. - Pipeline by Target, 2015
  • Asubio Pharma Co., Ltd. - Pipeline by Route of Administration, 2015
  • Asubio Pharma Co., Ltd. - Pipeline by Molecule Type, 2015
  • Asubio Pharma Co., Ltd. - Pipeline Products by Mechanism of Action, 2015
  • Asubio Pharma Co., Ltd. - Recent Pipeline Updates, 2015
  • Asubio Pharma Co., Ltd. - Dormant Developmental Projects,2015
  • Asubio Pharma Co., Ltd., Subsidiaries

List of Figures

  • Asubio Pharma Co., Ltd. - Pipeline by Top 10 Indication, 2015
  • Asubio Pharma Co., Ltd. - Pipeline by Stage of Development, 2015
  • Asubio Pharma Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Asubio Pharma Co., Ltd. - Pipeline by Top 10 Target, 2015
  • Asubio Pharma Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • Asubio Pharma Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top